We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
- Authors
Serrano, César; Mariño-Enríquez, Adrián; Tao, Derrick L.; Ketzer, Julia; Eilers, Grant; Zhu, Meijun; Yu, Channing; Mannan, Aristotle M.; Rubin, Brian P.; Demetri, George D.; Raut, Chandrajit P.; Presnell, Ajia; McKinley, Arin; Heinrich, Michael C.; Czaplinski, Jeffrey T.; Sicinska, Ewa; Bauer, Sebastian; George, Suzanne; Fletcher, Jonathan A.
- Abstract
The additional information of this manuscript originally stated that the authors declare no competing interests. This statement was incorrect, and should instead have stated the following:M.C.H. has the following competing interests to declare: Equity interest at Molecular MD; Consulting at Molecular MD, Blueprint Medicines, Deciphera Pharmaceuticals; Expert Testimony at Novartis; Licensed patent with royalty payments at Novartis. The remaining authors have no competing interests to declare.The authors apologise for any convenience this may have caused.
- Publication
British Journal of Cancer, 2019, Vol 121, Issue 3, p281
- ISSN
0007-0920
- Publication type
corrected article
- DOI
10.1038/s41416-019-0487-5